Providing Legal Help For Zantac (Ranitidine) Recall Victims

Posted by Lowe Eklund Wakefield Co., LPA on Jul 22, 2020 12:41:06 PM

In April of 2020 the Food And Drug Administration (FDA) issued a voluntary recall on all Zantac (sometimes called Ranitidine) products after discovering high levels of cancer-causing carcinogens in the drug.

Zantac is a popular over-the-counter heartburn medication. Prolonged use of Zantac and other generic drugs containing Ranitidine can increase the levels of N-Nitrosodimethylamine (NDMA), a cancer-causing carcinogen, within the human body over time. NDMA is known to cause cancers in the stomach, esophagus, bladder, prostate, breasts, kidneys, thyroid and other areas of the body.

Read More

Topics: product recalls, zantac, ranitidine, drug recall